ArticleTheranostics2026

c-Met-targeted NIR-II imaging for precision management of oral squamous cell carcinoma and premalignant lesions.

Zhipeng Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.